High path avian influenza has affected close to 170 million birds over the past three years.
USDA is working to combat the virus and lower egg prices through a new strategy, which includes funding for vaccine research.
American Farm Bureau Economist Bernt Nelson spoke with RFD-TV’s Suzanne Alexander about current HPAI vaccines and what is preventing the use of them.
Related Stories
Researchers out of the United Kingdom are using gene editing technology to help make High-Path Avian Flu less of a threat to poultry.
To mark the end of National Chicken Month, we take a look at how the U.S. poultry industry is making a slow and steady recovery following the widespread outbreak of High-Path Avian Flu (HPAI) in 2022 that devastated commercial flocks across the country.
Egg prices have been on a roller coaster this year, soaring sky-high and falling back down to Earth in just a few months.
In June, prices were down 77% compared to the highest weekly price in 2022.
According to the USDA Outlook Board, margins could improve for producers depending on a decrease in cases of High-Path Avian Flu (HPAI).
